Skip to main content
OpenTrials
Completed

NCT Number: NCT01812278

Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)

The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fred Hutchinson Cancer Research Center

Seattle, Washington, 98109, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 18 or older
  • smokes at least five cigarettes daily for at least past 12 months
  • wants to quit in next 30 days
  • willing to be randomly assigned to either group
  • resides in US
  • has at least weekly access to a high speed Internet connection and email
  • willing and able to read in English
  • not participating in other smoking cessation interventions (including our other intervention studies
  • has never used the Smokefree.gov website
  • willing to complete all three follow-up surveys
  • provide email, phone, and mailing address
  • provide contact information for two collaterals (e.g., relatives).
  • does not have family, friends, or other household members participating

Exclusion criteria

  • The exclusion criteria are the opposite of the inclusion criteria above.

Treatment and study plan

ACT

Behavioral

Other names: Acceptance & Commitment Therapy

CBT

Behavioral

Other names: Cognitive Behavioral Therapy

Primary outcomes

  1. 30-day point prevalence abstinence

    Time frame: 12 month post randomization

    No smoking in the past 30 days, as reported 12 month post treatment.

Secondary outcomes

  1. 7-day, 24-hour, and 30-day point prevalence quit rates

    Time frame: 3 months, 6 months, and 12 months post treatment

    12 months: 24-hour and 7-day point prevalence quit rates. 3 and 6 months: 24-hour, 7-day, and 30-day point prevalence quit rates. Across 3, 6, and 12 month timepoints, the repeated 30-day point prevalence abstinence.

Sponsors and collaborators

Lead sponsor

Fred Hutchinson Cancer Center

Other

Collaborators

  • Kaiser Permanente
  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)

Registry information

Official study title

Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation

Important dates

Study start
2014
Primary completion
2016
Study completion
2019
First posted
Mar 18, 2013
Registry last updated
Jul 31, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.